MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease

AIM To determine whether cell division cycle (Cdc)42 is regulated by microRNA (miR)-15a in the development of pediatric inflammatory bowel disease (IBD). METHODS We cultured 293T cells, used plasmids and performed dual-luciferase assay to determine whether Cdc42 is a miR-15a target gene. We cultured Caco-2 cells, and stimulated them with tumor necrosis factor (TNF)-α. We then employed lentiviruses to alter the expression of miR-15a and Cdc42. We performed quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunofluorescence to determine whether Cdc42 is regulated by miR-15a in Caco-2 cells. Finally, we collected ileocecal tissue by endoscopy from patients and performed qRT-PCR to examine the expression of miR-15a and Cdc42 in pediatric IBD patients. RESULTS Target Scan and dual-luciferase assay revealed that Cdc42 was a miR-15a target gene. MiR-15a expression increased (P = 0.0038) and Cdc42 expression decreased (P = 0.0013) in cells stimulated with TNF-α, and the expression of the epithelial junction proteins zona occludens (ZO)-1 (P < 0.05) and E-cadherin (P < 0.001) decreased. Cdc42 levels decreased in miR-15a-mimic cells (P < 0.001) and increased in miR-15a inhibitor cells (P < 0.05). ZO-1 and E-cadherin decreased in miR-15a-mimic cells (P < 0.001) but not in the miR-15a inhibitor + TNF-α cells. In Lv-Cdc42 + TNF-α cells, ZO-1 and E-cadherin expression increased compared to the Lv-Cdc42-NC + TNF-α (P < 0.05) or miR-15a-mimic cells (P < 0.05). Fifty-four pediatric IBD patients were included in this study, 21 in the control group, 19 in the Crohn’s disease (CD) active (AC) group, seven in the CD remission (RE) group, and seven in the ulcerative colitis (UC) group. MiR-15a increased and Cdc42 decreased in the CD AC group compared to the control group (P < 0.05). miR-15a decreased and Cdc42 increased in the CD RE group compared to the CD AC group (P < 0.05). miR-15a was positively correlated with the Pediatric Crohn’s disease Activity Index (PCDAI) (P = 0.006), while Cdc42 was negatively correlated with PCDAI (P = 0.0008). Finally, miR-15a expression negatively correlated with Cdc42 in pediatric IBD patients (P = 0.0045). CONCLUSION MiR-15a negatively regulates epithelial junctions through Cdc42 in Caco-2 cells and pediatric IBD patients.

[1]  D. Turner,et al.  [ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents]. , 2016, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[2]  A. Hart,et al.  Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. , 2016, World journal of gastroenterology.

[3]  G. Veres,et al.  Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.

[4]  M. Elvers.  RhoGAPs and Rho GTPases in platelets. , 2015, Hamostaseologie.

[5]  Yuanshuai Fu,et al.  miR-17 is involved in Japanese Flounder (Paralichthys olivaceus) development by targeting the Cdc42 mRNA. , 2016, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[6]  Junnan Wang,et al.  MicroRNA-137 Negatively Regulates H2O2-Induced Cardiomyocyte Apoptosis Through CDC42 , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[7]  Yanqing Ding,et al.  Down-regualtion of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer. , 2015, International journal of clinical and experimental pathology.

[8]  T. Sanchez-Elsner,et al.  MicroRNAs in Inflammatory Bowel Diseases: Paradoxes and Possibilities , 2015, Inflammatory bowel diseases.

[9]  A. Hall,et al.  Functional cross-talk between Cdc42 and two downstream targets, Par6B and PAK4. , 2015, The Biochemical journal.

[10]  A. Prakash,et al.  Current scenario in inflammatory bowel disease: Drug development prospects , 2015, Pharmacological reports : PR.

[11]  J. Lindsay,et al.  Defects in the adherens junction complex (E-cadherin/ β-catenin) in inflammatory bowel disease , 2015, Cell and Tissue Research.

[12]  Yutao Yan,et al.  Protein kinases are potential targets to treat inflammatory bowel disease. , 2014, World journal of gastrointestinal pharmacology and therapeutics.

[13]  D. Mccole.  IBD Candidate Genes and Intestinal Barrier Regulation , 2014, Inflammatory bowel diseases.

[14]  J. El-Benna,et al.  Tumor Necrosis Factor-α-Induced Colitis Increases NADPH Oxidase 1 Expression, Oxidative Stress, and Neutrophil Recruitment in the Colon: Preventive Effect of Apocynin , 2014, Mediators of inflammation.

[15]  Weixu Chen,et al.  Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. , 2014, World journal of gastrointestinal pathophysiology.

[16]  Noah C. Welker,et al.  Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity , 2014, Modern Pathology.

[17]  E. Nimmo,et al.  Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics , 2013, Gastroenterology.

[18]  C. Akdis,et al.  MicroRNAs: Essential players in the regulation of inflammation. , 2013, The Journal of allergy and clinical immunology.

[19]  J. Raisch,et al.  Role of microRNAs in the immune system, inflammation and cancer. , 2013, World journal of gastroenterology.

[20]  M. Gazouli,et al.  The role of variations within microRNA in inflammatory bowel disease , 2013, European journal of gastroenterology & hepatology.

[21]  Xiaojun Wang,et al.  Inflammatory Bowel Disease in Chinese Children: A Multicenter Analysis Over a Decade from Shanghai , 2013, Inflammatory bowel diseases.

[22]  Pietro Invernizzi,et al.  MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. , 2012, Autoimmunity reviews.

[23]  A. Harada,et al.  Cdc42 and Rab8a are critical for intestinal stem cell division, survival, and differentiation in mice. , 2012, The Journal of clinical investigation.

[24]  C. Germer,et al.  Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro , 2011, Journal of cellular physiology.

[25]  Y. Naito,et al.  Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis , 2010, Journal of gastroenterology and hepatology.

[26]  S. Hogan,et al.  Intestinal barrier function: molecular regulation and disease pathogenesis. , 2009, The Journal of allergy and clinical immunology.

[27]  A. Hall,et al.  Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis , 2008, The Journal of cell biology.

[28]  S. Brant,et al.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. , 2008, Gastroenterology.

[29]  Carola Förster,et al.  Tight junctions and the modulation of barrier function in disease , 2008, Histochemistry and Cell Biology.

[30]  Linda Yang,et al.  Cdc42: A Signal Coordinator in Hematopoietic Stem Cell Maintenance , 2007, Cell cycle.